- Net Sales: ¥867M
- Operating Income: ¥42M
- Net Income: ¥37M
- EPS: ¥7.65
| Item | Current | Prior | YoY % |
|---|
| Net Sales | ¥867M | ¥767M | +13.0% |
| Cost of Sales | ¥327M | - | - |
| Gross Profit | ¥441M | - | - |
| SG&A Expenses | ¥402M | - | - |
| Operating Income | ¥42M | ¥38M | +10.5% |
| Non-operating Income | ¥885,000 | - | - |
| Non-operating Expenses | ¥1M | - | - |
| Ordinary Income | ¥47M | ¥38M | +23.7% |
| Profit Before Tax | ¥12M | - | - |
| Income Tax Expense | ¥6M | - | - |
| Net Income | ¥37M | ¥6M | +516.7% |
| Depreciation & Amortization | ¥19M | - | - |
| Interest Expense | ¥47,000 | - | - |
| Basic EPS | ¥7.65 | ¥1.30 | +488.5% |
| Diluted EPS | ¥7.59 | ¥1.30 | +483.8% |
| Dividend Per Share | ¥0.00 | ¥0.00 | - |
| Item | Current End | Prior End | Change |
|---|
| Current Assets | ¥1.14B | - | - |
| Cash and Deposits | ¥860M | - | - |
| Accounts Receivable | ¥196M | - | - |
| Non-current Assets | ¥220M | - | - |
| Property, Plant & Equipment | ¥27M | - | - |
| Item | Current | Prior | Change |
|---|
| Operating Cash Flow | ¥89M | - | - |
| Financing Cash Flow | ¥-18M | - | - |
| Item | Value |
|---|
| Net Profit Margin | 4.3% |
| Gross Profit Margin | 50.8% |
| Current Ratio | 410.9% |
| Quick Ratio | 410.9% |
| Debt-to-Equity Ratio | 0.25x |
| Interest Coverage Ratio | 893.62x |
| EBITDA Margin | 7.1% |
| Effective Tax Rate | 48.3% |
| Item | YoY Change |
|---|
| Net Sales YoY Change | +13.0% |
| Operating Income YoY Change | +10.2% |
| Ordinary Income YoY Change | +24.6% |
| Net Income YoY Change | +494.6% |
| Item | Value |
|---|
| Shares Outstanding (incl. Treasury) | 4.84M shares |
| Average Shares Outstanding | 4.84M shares |
| Book Value Per Share | ¥231.35 |
| EBITDA | ¥61M |
| Item | Amount |
|---|
| Q2 Dividend | ¥0.00 |
| Year-End Dividend | ¥0.00 |
| Item | Forecast |
|---|
| Net Sales Forecast | ¥2.00B |
| Operating Income Forecast | ¥160M |
| Ordinary Income Forecast | ¥162M |
| Net Income Forecast | ¥129M |
| Basic EPS Forecast | ¥26.89 |
| Dividend Per Share Forecast | ¥0.00 |
This data was automatically extracted from XBRL files. Please refer to the original disclosure documents for accuracy.
Verdict: Solid top-line growth with modest operating leverage and strong cash conversion, but profitability remains thin and tax/line-item inconsistencies warrant caution. Revenue rose 13.0% YoY to 8.67, while operating income increased 10.2% YoY to 0.42, indicating growth but slightly slower operating leverage than sales. Ordinary income expanded 24.6% YoY to 0.47, outpacing operating income, suggesting some non-operating tailwinds despite non-operating items being largely immaterial this quarter. Net income surged to 0.37 (+494.6% YoY) from a very low base, lifting the net margin to 4.3%. Gross profit was 4.41, yielding a gross margin of 50.8%, and SG&A was 4.02, or 46.4% of sales, reflecting a high but manageable cost structure. Operating margin is approximately 4.8% (0.42/8.67), with an estimated YoY compression of roughly 13 bps given revenue outpaced operating profit. Ordinary income margin improved about 51 bps YoY to ~5.4%, while net margin expanded by an estimated 346 bps YoY from ~0.8% due to the low prior-year base. Cash generation was strong: operating cash flow was 0.89, about 2.39x net income, indicating high earnings quality. The balance sheet is liquid with cash and deposits of 8.60 versus current liabilities of 2.78, yielding a current ratio of 410.9% and quick ratio of 410.9%. Total assets were 13.90 with equity of 11.20, implying low financial leverage (assets/equity 1.24x). Despite healthy liquidity, retained earnings remain negative (-5.00), underscoring limited accumulated profits historically. The effective tax rate appears elevated at 48.3%, which could temper net profitability if sustained. There is an internal consistency issue in the P/L (profit before tax 0.12 vs net income 0.37) that likely reflects unreported extraordinary items or presentation differences under JGAAP; this limits precision in tax and below-the-line analysis. Capex was modest at 0.08, and a proxy FCF (OCF - capex) is about 0.81, supporting reinvestment flexibility. Forward-looking, the company’s ability to curb SG&A ratio, sustain >50% gross margin, and normalize the tax rate will determine whether ROE can rise meaningfully above the current 3.3%. Near-term, strong liquidity and cash conversion provide a buffer to execute on growth without external financing.
ROE decomposition (DuPont): ROE 3.3% = Net Profit Margin (4.3%) × Asset Turnover (0.624) × Financial Leverage (1.24x). The largest change driver versus last year appears to be net profit margin, given net income grew +494.6% on +13.0% revenue, while asset turnover and leverage are relatively stable for a cash-rich, low-debt balance sheet. Business explanation: margin uplift stems from improved ordinary income and a very low prior-year net base, while operating margin leverage was mild as SG&A grew roughly in line with sales (SG&A ratio 46.4%). Sustainability: operating margin gains look fragile (only ~-13 bps YoY compression estimated), but the step-up in net margin is partly base-effect driven and may normalize if the tax rate stays high or if non-operating tailwinds fade. Concerning trends: SG&A intensity remains high at 46.4% of revenue; with operating margin at ~4.8%, any slowdown in sales growth could pressure profits. Asset turnover at 0.624 is reasonable for a service/data business, but meaningful ROE improvement likely requires either faster revenue growth than operating expenses or higher pricing/mix to lift gross and operating margins.
Revenue growth of +13.0% YoY to 8.67 is healthy, suggesting resilient demand for the company’s data/analytics offerings. Operating income grew +10.2%, indicating modest operating leverage but also signaling that cost growth (notably SG&A) remains a headwind. Ordinary income rose +24.6%, implying minor non-operating support, though reported non-operating income/expenses were near zero; this may reflect classification effects or small below-OP items. Net income’s +494.6% YoY jump reflects prior-year weakness and some below-the-line effects, not a structural profitability reset. Gross margin at 50.8% is solid for a data-driven model and provides headroom if scale effects can lower unit SG&A. With EBITDA at 0.61 (7.1% margin), additional scale is needed for durable double-digit EBITDA margins. Outlook hinges on sustaining double-digit sales growth while compressing the SG&A ratio by 100–200 bps over the next few quarters; absent that, ROE uplift will be limited. The elevated effective tax rate (48.3%) is a drag; normalization toward statutory rates would support net margins. Overall, growth looks organic and recurring-like, but confirmation via cohort retention, upsell rates, and contract backlog would strengthen confidence (not disclosed).
Liquidity is strong: current assets 11.42 vs current liabilities 2.78 yields a current ratio of 410.9% and ample working capital of 8.64. Quick ratio equals current ratio (410.9%) due to negligible inventories, and cash 8.60 alone covers current liabilities ~3.1x. Solvency: total liabilities are 2.82 and equity 11.20; reported D/E of 0.25x indicates conservative leverage. Interest-bearing debt is unreported; interest expense is de minimis (0.00) and interest coverage is 893.6x, implying negligible financing risk. No warnings: Current Ratio >> 1.0 and D/E well below 2.0. Maturity mismatch risk appears low given cash dominance on the asset side and small payables (0.51). Off-balance sheet obligations are not disclosed; absence of lease/commitment detail is a data limitation under single-entity JGAAP reporting.
Earnings quality is high this period: OCF/Net income at 2.39x signals cash conversion well above earnings. OCF of 0.89 vs EBITDA of 0.61 suggests favorable working capital (or low non-cash charges beyond D&A of 0.19). Proxy FCF (OCF - capex) is approximately 0.81, indicating capacity to self-fund modest growth investments; full FCF cannot be confirmed as investing CF is unreported. Working capital appears healthy: accounts receivable 1.96 against half-year revenue 8.67 implies DSO roughly ~41 days; payables 0.51 vs cost of sales 3.27 suggests DPO ~28 days; with no inventories reported, the cash conversion cycle is short. No obvious signs of working capital manipulation are evident from the limited data. Financing CF was -0.18, but without dividend/buyback detail we cannot attribute the outflow; leverage remains very low.
Dividend disclosures are unreported; payout ratios and total dividends paid are N/A. With negative retained earnings (-5.00) but strong cash reserves (8.60) and positive proxy FCF (~0.81), the company has cash capacity but limited accumulated profits under JGAAP, which can constrain distributions. If a dividend policy were adopted, sustainability would hinge on maintaining OCF > capex and preserving liquidity buffers. In the absence of a disclosed policy and given the small scale and ongoing need to invest in growth, a conservative stance on distributions is implied. FCF coverage of any potential dividend cannot be assessed precisely without full investing CF detail.
Business Risks:
- High SG&A intensity (46.4% of sales) limits operating leverage and leaves earnings sensitive to growth shortfalls.
- Small scale (revenue 8.67 for the half-year) increases volatility to client/order timing.
- Potential client concentration and contract renewal risk typical for data/analytics businesses (not disclosed).
- Data privacy and compliance risk inherent to handling consumer/retail data.
- Talent retention/recruiting risk in analytics/engineering roles, which drive delivery capacity and cost base.
Financial Risks:
- Negative retained earnings (-5.00) despite positive current profits, constraining distributable reserves.
- Elevated effective tax rate (48.3%) depresses net margin and could remain volatile.
- Thin operating margin (~4.8%) offers limited cushion against revenue shocks.
- Information gaps (investing CF, debt details, dividend data) hinder full assessment of obligations.
Key Concerns:
- P/L inconsistency (profit before tax 0.12 vs net income 0.37) suggests unreported extraordinary items or classification differences under JGAAP.
- Slight operating margin compression despite double-digit sales growth indicates cost pressure.
- Reliance on cash-heavy balance sheet; while liquidity is strong, returns (ROE 3.3%) remain modest.
- Tax normalization path unclear; sustained ~48% effective rate would cap ROE expansion.
Key Takeaways:
- Top-line growth is healthy (+13% YoY) with stable gross margin (50.8%).
- Operating leverage is modest; SG&A ratio remains high at 46.4%.
- Cash conversion is strong (OCF/NI 2.39x), supporting self-funding of operations.
- Balance sheet is very liquid (cash 8.60 vs CL 2.78) with low leverage (assets/equity 1.24x).
- ROE at 3.3% is constrained by thin margins and low leverage; margin management is key.
- Effective tax rate is elevated, suppressing net profitability.
- Negative retained earnings highlight limited historical profitability despite current improvements.
Metrics to Watch:
- SG&A to sales ratio and trajectory (target sustained reduction of 100–200 bps).
- Operating margin progression vs revenue growth.
- OCF/NI ratio and working capital metrics (DSO, DPO) for cash conversion stability.
- Gross margin stability around >50%.
- Effective tax rate normalization.
- Capex and product investment intensity vs sales.
- Order backlog/ARR/retention metrics (if disclosed) to validate recurring growth.
Relative Positioning:
Within small-cap Japanese data/analytics peers, the company exhibits strong liquidity and cash conversion but lags on profitability scale, with ROE below peer leaders. Execution on SG&A efficiency and tax normalization would be required to close the profitability gap.
This analysis was auto-generated by AI. Please note the following:
- No Guarantee of Accuracy: The accuracy and completeness of this analysis are not guaranteed. For accurate financial data, please refer to the original disclosure documents published on TDnet or other official sources
- Not Investment Advice: This analysis is for general informational purposes only and does not constitute investment advice under applicable securities laws. It is not a recommendation to buy or sell any specific securities
- At Your Own Risk: Investment decisions should be made at your own discretion and risk. We assume no liability for any losses incurred based on this analysis